Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Advanced Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03009214
What this trial is testing

A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours

Who this might be right for
Malignant Solid Tumor
amcure GmbH 55
Early research (Phase 1)Study completedNCT00721266
What this trial is testing

A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 102
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Early research (Phase 1)Not Yet RecruitingNCT07612488
What this trial is testing

CS231295 in Patients With Advanced Solid Tumors

Who this might be right for
Advance Solid TumorsAdvanced Malignant Solid Tumors
ThalassaX Therapeutics United States Ltd 42
Early research (Phase 1)Study completedNCT00880568
What this trial is testing

Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED)

Who this might be right for
NeoplasmsMalignant
Merck Sharp & Dohme LLC 27
Testing effectiveness (Phase 2)Looking for participantsNCT07105215
What this trial is testing

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Who this might be right for
Solid Tumors
RemeGen Co., Ltd. 312
Not applicableActive Not RecruitingNCT04989556
What this trial is testing

Technology-Enhanced Palliative Care for Advanced Cancer Patients

Who this might be right for
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center 119
Early research (Phase 1)Study completedNCT00927966
What this trial is testing

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

Who this might be right for
SarcomaSolid Tumor
Suzanne George, MD 21
Early research (Phase 1)UnknownNCT01107522
What this trial is testing

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Who this might be right for
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Tactical Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06016062
What this trial is testing

RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 221
Not applicableLooking for participantsNCT00870129
What this trial is testing

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

Who this might be right for
Brain CancerGlioma
Memorial Sloan Kettering Cancer Center 135
Early research (Phase 1)Study completedNCT01125891
What this trial is testing

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Who this might be right for
Malignant NeoplasmasSolid Tumors
Traws Pharma, Inc. 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Looking for participantsNCT06566079
What this trial is testing

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Who this might be right for
Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor
InSilico Medicine Hong Kong Limited 160
Early research (Phase 1)Study completedNCT03726294
What this trial is testing

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer

Who this might be right for
Malignant Neoplasm
NatureWise Biotech & Medicals Corporation 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06112041
What this trial is testing

The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)

Who this might be right for
CarcinomaSolid Tumor
Second Affiliated Hospital of Soochow University 29
Testing effectiveness (Phase 2)Looking for participantsNCT06534762
What this trial is testing

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Who this might be right for
NSCLCSCLCColorectal Cancer+4 more
Zhejiang Provincial People's Hospital 260
Early research (Phase 1)Study completedNCT01930552
What this trial is testing

A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies

Who this might be right for
Neoplasm Malignant
Sanofi 20
Early research (Phase 1)Study completedNCT01140607
What this trial is testing

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Who this might be right for
Neoplasm Malignant
Sanofi 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07665970
What this trial is testing

SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Sinocelltech Ltd. 112
Next Page